查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1442903

感染預防與對策 - 全球市場考量、競爭格局、市場預測（2030）

Infection Prevention and Control - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計2024年至2030年期間，全球感染預防及控制市場規模將以6.13%的複合年增長率大幅成長。感染預防和控制的需求主要是由於慢性病患病率不斷上升、需要高強度感染預防的外科手術增加、醫院感染增加以及政府加強確保先進的感染預防而增長。在醫療行業，不斷增加的產品推出、產品開發的技術創新等，正在推動2024-2030年預測期內感染預防和控制市場的整體成長。

感染預防的市場動態及對策

預計全球醫院感染的流行將在預測期內加強醫院感染預防市場。

例如，根據世界衛生組織 (WHO) (2022) 的數據，估計全世界每年有數億人受到醫療保健相關感染 (HAI) 的影響，其中許多感染是完全可以避免的。

數據顯示，每100名患者中有7名來自高收入國家，15名來自中低收入國家。世界衛生組織也得出結論，在全球範圍內，十分之一的受影響患者死於醫院感染。

從這些數字中，我們可以得出結論，全世界醫院感染的盛行率正在增加。透過保持適當的手部衛生、佩戴口罩和手套等防護裝備、對污染區域進行消毒以及對醫院使用的所有設備進行適當消毒等不良做法，可以降低因感染而增加的發病率和死亡率。措施。因此，上述因素將推動預測期內感染預防和控制的整體市場成長。

環境污染、吸菸、不健康的生活方式、營養和飲食，包括發炎性腸道疾病（IBD）、胃食道逆流（GERD）、消化性潰瘍、克隆氏症、糖尿病、高血壓、心血管疾病和癌症。慢性病盛行率上升由於生活方式的紊亂和大量致癌物質的攝入將推動感染預防和控制產品和設備的市場。

例如，根據International Diabetes Federation的《Diabetes Atlas第10版報告》（2021年），2021年全球有5.37億成年人（20-79歲）患有糖尿病。預計到 2030 年，這一數字將增至 6.43 億，到 2045 年將增至 7.83 億。慢性病盛行率的增加也增加了外科手術的數量並增加了感染的風險。透過遵循適當的滅菌和消毒技術以及使用各種感染來預防和控制產品，例如手部和表面消毒劑、手套和口罩，可以阻止傳染病。

因此，由於慢性病盛行率上升而導致的外科手術數量的增加可能會增加醫院感染的盛行率，從而增加對感染預防和控制產品的需求。

此外，政府機構正在積極發佈指導方針，旨在提高全球對有效預防措施的認識，預計這將在預測期內的市場成長中發揮重要作用。例如，世界衛生組織（WHO）發佈了衛生行業預防和管理急性呼吸道疾病的指南，這些疾病使人們容易患上流行病和流行病。建議從常識性安全措施（例如經常洗手）到使用個人防護裝備以及滅菌和消毒的說明。

因此，上述因素將在2024-2030年預測期內推動感染預防和控制市場。

然而，化學消毒劑的不利影響以及對再加工器械安全性的嚴格監管要求可能會抑制感染防治市場的整體成長。

感染防治市場細分分析

在感染預防和控制市場的產品類型細分市場中，洗手液類別預計將在2023年獲得可觀的收入佔有率。這可以歸因於與該細分市場相關的好處和用途。

洗手液可以在很短的時間內殺死表面上的細菌和病毒。此外，洗手液通常無毒、無刺激、便宜且不會引起過敏。

本報告研究和分析了全球感染預防和控制市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

目錄

第一章感染預防與對策市場報告簡介

第二章感染預防與對策市場概要

  • 調查範圍
  • 市場概況
  • 競爭評估

第三章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章感染防治市場主要因素分析

  • 感染預防和控制市場的驅動因素
  • 感染防治市場的抑制因素與挑戰
  • 感染防控市場機遇

第五章感染防治市場波特五力分析

第六章 感染防治市場佈局

  • 依產品
    • 機器
    • 消耗品
  • 依最終用戶
    • 醫院/診所
    • 醫療器材企業、製藥公司
    • 其他
  • 區域
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第七章 感染防治市場企業及產品概況

  • 3M
  • Fortive
  • Medivators Inc
  • Getinge AB
  • MELAG Medizintechnik GmbH & Co. KG
  • Metrex Research, LLC
  • MMM Group
  • STERIS
  • Sotera Health LLC
  • Nanosonics
  • BD
  • Owens & Minor
  • Matachana Group
  • Xenex Disinfection Services Inc.
  • Ecolab
  • bombayengg
  • Pal International
  • BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD.
  • Miele Group
  • Belimed AG

第8章 KOL觀點

第9章 專案方法

第10章 DelveInsight服務內容

第 11 章關於 DelveInsight

第 12 章免責聲明，聯絡我們

Product Code: DIMDCL0689

Infection Prevention And Control Market By Product (Equipment [Sterilization Equipment {Heat Sterilization Equipment, Low-Temperature Sterilization Equipment, Radiation Sterilization, And Others} And Disinfectors {Washers, Flushes, Endoscope Reprocessors, And Others}] And Consumables [Disinfectants {Hand Disinfectants, Surface Disinfectants, Skin Disinfectants, And Others}, Personal Protective Equipment {Surgical Drapes, Surgical Gowns, Gloves, And Others}, Sterilization Consumables, Infectious Waste Disposal, And Others]), End-User (Hospitals & Clinics, Medical Device And Pharmaceutical Companies, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of hospital-acquired infection and growing number of surgical procedures that require high-intensity infection prevention

The global infection prevention and control market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 6.13% during the forecast period from 2024 to 2030. The demand for infection prevention and control is primarily being boosted by the increasing prevalence of increasing incidence of chronic diseases, the growing number of surgical procedures that require high-intensity infection prevention, growing figures of hospital-acquired infections, the rising number of government initiatives to ensure a high degree of infection prevention, growing healthcare industry, increasing product launches, and innovation in product development among others, thereby contribute to the overall growth of the infection prevention and control market during the forecast period from 2024-2030.

Infection Prevention And Control Market Dynamics:

The increasing prevalence of hospital-acquired infection globally is anticipated to bolster the market for hospital-acquired infection control during the forecasted period.

For instance, according to the World Health Organization (WHO) 2022, it was estimated that globally hundreds of millions of people every year are affected by healthcare-associated infections (HAIs), many of which are completely avoidable.

As per the same source, it was reported that out of every 100 patients, 7 patients are in high- and 15 patients in low or middle-income countries. WHO also concluded that globally, 1 in every 10 affected patients dies of a hospital-acquired infection.

From the above figures, it can be concluded that the prevalence of hospital-acquired infection is increasing globally. The increasing prevalence and mortality from the infection can be controlled by following proper measures such as maintaining proper hand hygiene, wearing masks, gloves, and other protective gear, disinfecting the area subjected to contamination, and following proper sterilization of all the equipment used in the hospitals; thereby increasing the demand of infection prevention and control products across the globe. Thus, the above factor will be responsible in propelling the overall market growth of infection prevention and control during the forecast period.

The rise in prevalence of chronic diseases like inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), peptic ulcer disease, Crohn's disease, diabetes, hypertension, cardiovascular disorders, cancer, and others due to environmental pollution, smoking, unhealthy lifestyles, poor nutrition and diet, and high intake of carcinogenic substances will drive the market of infection prevention and control product and devices.

For instance, according to the International Diabetes Federation, Diabetes Atlas 10th edition report 2021, globally 537 million adults (20-79 years) were living with diabetes in 2021. This number is predicted to rise to 643 million by 2030 and 783 million by 2045. The rising prevalence of chronic disease will also increase the number of surgical procedures which in turn will increase the risk of infections. The transition of infections can be ceased by following proper sterilization and disinfectant techniques and also by using various infection prevention and control products such as hand or surface disinfectant, gloves, masks, and others.

Therefore, the rising number of surgical procedures owing to the rising prevalence of chronic disorders may increase the prevalence of hospital-acquired infections ultimately increasing the demand for infection prevention and control products.

In addition, government agencies are likely to play a larger role in the market's growth throughout the forecast period as they become more active in the issuance of guidelines aimed at raising global awareness of effective preventive measures. For example, the World Health Organization (WHO) has published guidelines for the healthcare industry's prevention and management of acute respiratory disorders that are susceptible to pandemics and epidemics. The recommendations cover anything from common sense safety measures like washing your hands often to using personal protective equipment and instructions for sterilizing and disinfecting.

Therefore, the above-mentioned factors will propel the infection prevention and control market during the forecast period from 2024-2030.

However, adverse effects of chemical disinfectants, stringent regulatory requirements with concerns for the safety of reprocessed instruments, and others may restrict the growth of the overall infection prevention and control market.

Infection Prevention And Control Market Segment Analysis:

Infection Prevention and Control Market by Product (Equipment [Sterilization Equipment {Heat Sterilization Equipment, Low-Temperature Sterilization Equipment, Radiation Sterilization, and Others} and Disinfectors {Washers, Flushes, Endoscope Reprocessors, and Others}] and Consumables [Disinfectants {Hand Disinfectants, Surface Disinfectants, Skin Disinfectants, and Others}, Personal Protective Equipment {Surgical Drapes, Surgical Gowns, Gloves, and Others}, Sterilization Consumables, Infectious Waste Disposal, and Others]), End-User (Hospitals & Clinics, Medical Device And Pharmaceutical Companies, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the infection prevention and control market, the hand disinfectants category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications associated with the segment.

Hand disinfectants take very little time to kill the bacteria or viruses present on any surface. Additionally, hand disinfectants are generally nontoxic, non-irritating, inexpensive, and non-allergenic.

Hand disinfectants are easily portable therefore they can be used anywhere. It not only kills germs but prevents the transmission of germs from one person to another.

Further, alcohol-based hand disinfectants effectively reduce the bacterial counts on hands better than soap and water. Alcohol-based hand disinfectants are more effective against most bacteria and many viruses than either medicated or non-medicated soaps.

In addition, the usage of hand disinfectants was higher in hospitals during the pandemic as the number of hospitalizations increased during this time. The prime aim of hand disinfectants was to provide protection in healthcare facilities and safeguard personnel performing medical procedures that expose them to the virus.

Moreover, the product launches in the local market, in turn, drive the product demand in the market. For instance, in May 2020, Dukes India launched hand sanitizers, a type of hand disinfectant named Hand Safe, to help combat the COVID-19 virus.

Also, in June 2020, Cadila Pharmaceuticals launched a range of hand sanitizers, under the brand name Santiza and Laglo.

Therefore, owing to the above-mentioned factors, the hand disinfectants category is expected to register significant growth, thereby driving the growth of the overall infection prevention and control market during the forecast period.

North America is expected to dominate the overall Infection Prevention And Control Market:

Among all the regions, North America is estimated to account for the largest share of the infection prevention and control market in the year 2023. Owing to the significance of key growth factors such as the growing incidence of chronic diseases such as cancer, kidney disease, Crohn's disease, growing incidence of hospital-acquired infections and the high geriatric population, and high awareness about the advantages of proper infection prevention and control, consistent number of strategic collaborations, growing presence of outsourcing organizations, growing healthcare expenditure, unprecedented evolution of the healthcare standards and infrastructure, and others, the market for infection prevention and control is expected to witness prosperity in the region during the forecast period 2024-2030.

According to the Centers for Disease Control and Prevention (CDC), 2020 Annual National and State Healthcare-Associated Infections (HAI) Progress Report, it was estimated that between 2019 and 2020 in the United States, about 24% increase seen in central line-associated bloodstream infections (CLABSI) with the largest increase in infections transmitted from ICU.

The increasing prevalence of hospital-acquired infections will in turn increase the demand for infection prevention and control devices and consumables in the United States.

Further, a consistent number of strategic collaborations adopted by key market players to widen their product portfolio and infection control capabilities are believed to be responsible for the greater share captured by this region. For instance, In March 2023, Getinge completed the acquisition of Ultra Clean Systems Inc., a leading US manufacturer of ultrasonic cleaning technologies, used in hospitals and surgery centers to decontaminate surgical instruments. Ultrasonic cleaning is an integral part of best practices for reprocessing instruments, especially the most complex ones used for robotic surgery, to minimize the risk of hospital-acquired infections

Also, in March 2019, Getinge announced the US launch of a new 9100E Cart Washer. The 9100E Cart Washer represents the evolution of the company's successful 9100 series floor-loading cart and utensil washer-disinfectors. It was specifically designed to address the needs of hospitals, which require washers that have a reliable and sufficient throughput of a large variety of items that cannot be disinfected in a traditional instrument washer-disinfector, such as operating table transport trolleys, instrument containers, and other bulky items.

Thus, the above-mentioned factors are likely to propel the growth of the infection prevention and control market in the region during the forecast period from 2024-2030.

Infection Prevention And Control Market Key Players:

Some of the key market players operating in the infection prevention and control market include 3M, Fortive, Medivators Inc., Getinge AB, MELAG Medizintechnik GmbH & Co. KG, Metrex Research, LLC, MMM Group, STERIS, Sotera Health LLC, Nanosonics, BD, Owens & Minor, Matachana Group, Xenex Disinfection Services Inc., Ecolab, Bombayengg, Pal International, BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD., Miele Group, Belimed AG, and others.

Recent Developmental Activities in the Infection Prevention And Control Market:

  • In August 2021, Advanced Sterilization Products, a Fortive company, launched the STERRAD VELOCITY, a biological Indicator (BI)/process challenge device (PCD) in the Asia Pacific region.
  • In June 2021, Nanosonics announced the launch of Nanosonics AuditPro, a new infection prevention digital product platform.
  • In June 2021, STERIS plc completed the previously announced acquisition of Cantel Medical, a global provider of infection prevention products and services to endoscopy, dental, dialysis, and life sciences Customers.

Key Takeaways from the Infection Prevention And Control Market Report Study

  • Market size analysis for current infection prevention and control market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global infection prevention and control market.
  • Various opportunities available for the other competitors in the infection prevention and control market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current infection prevention and control market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for infection prevention and control market growth in the coming future?

Target Audience who can be benefited from this Infection Prevention And Control Market Report Study

  • Infection prevention and control product providers
  • Research organizations and consulting companies
  • Infection prevention and control-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in infection prevention and control
  • Various End-users who want to know more about the infection prevention and control market and the latest technological developments in the infection prevention and control market.

Frequently Asked Questions for the Infection Prevention And Control Market:

1. What is infection prevention and control?

Infection control products are concerned with the prevention or control of infection in healthcare settings, such as laboratories, hospitals, and others.

2. What is the market for global infection prevention and control?

The global infection prevention and control market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 6.13% during the forecast period from 2024 to 2030.

3. What are the drivers for the global infection prevention and control market?

The demand for infection prevention and control is primarily being boosted by the increasing incidence of hospital-acquired infections, the growing number of surgical procedures that require high-intensity infection prevention, the increasing incidence of chronic diseases along with the increasing geriatric population, increasing product launches, and others thereby contributing to the overall growth of the infection prevention and control market during the forecast period from 2024-2030.

4. Who are the key players operating in the global infection prevention and control market?

Some of the key market players operating in the infection prevention and control market include 3M, Fortive, Medivators Inc., Getinge AB, MELAG Medizintechnik GmbH & Co. KG, Metrex Research, LLC, MMM Group, STERIS, Sotera Health LLC, Nanosonics, BD, Owens & Minor, Matachana Group, Xenex Disinfection Services Inc., Ecolab, Bombayengg, Pal International, BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD., Miele Group, Belimed AG, and others.

5. Which region has the highest share in the infection prevention and control market?

North America is expected to dominate the overall infection prevention and control market during the forecast period from 2024-2030. Owing to factors such as the growing incidence of chronic diseases such as cancer, kidney disease, and Crohn's disease, the growing incidence of hospital-acquired infections and the high geriatric population, and high awareness about the advantages of proper infection prevention and control, a consistent number of strategic collaborations, growing presence of outsourcing organizations, growing healthcare expenditure, and unprecedented evolution of the healthcare standards and infrastructure, among others, the North America infection prevention and control market is expected to growth in coming years.

Table of Contents

1. Infection Prevention and Control Market Report Introduction

2. Infection Prevention and Control Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Infection Prevention and Control Market Key Factors Analysis

  • 4.1. Infection Prevention and Control Market Drivers
    • 4.1.1. Increasing incidence of hospital-acquired infections
    • 4.1.2. Growing number of surgical procedures that require high-intensity infection prevention
    • 4.1.3. Increasing incidence of chronic diseases along with increasing geriatric population
  • 4.2. Infection Prevention and Control Market Restraints and Challenges
    • 4.2.1. Adverse effects of chemical disinfectants
    • 4.2.2. Stringent regulatory requirements along with concerns for the safety of reprocessed instruments
  • 4.3. Infection Prevention and Control Market Opportunities
    • 4.3.1. Increasing outsourcing of sterilization services
    • 4.3.2. Increasing adoption of disinfectant robots

5. Infection Prevention and Control Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Infection Prevention and Control Market Layout

  • 6.1. By Product
    • 6.1.1. Equipment
      • 6.1.1.1. Sterilization Equipment
      • 6.1.1.1.1. Heat Sterilization Equipment
      • 6.1.1.1.2. Low-Temperature Sterilization Equipment
      • 6.1.1.1.3. Radiation Sterilization
      • 6.1.1.1.4. Other Products
      • 6.1.1.2. Disinfectors
      • 6.1.1.2.1. Washers
      • 6.1.1.2.2. Flushes
      • 6.1.1.2.3. Endoscope Reprocessors
      • 6.1.1.2.4. Others
    • 6.1.2. Consumables
      • 6.1.2.1. Disinfectants
      • 6.1.2.1.1. Hand Disinfectants
      • 6.1.2.1.2. Surface Disinfectants
      • 6.1.2.1.3. Skin Disinfectants
      • 6.1.2.1.4. Others
      • 6.1.2.2. Personal Protective Equipment
      • 6.1.2.2.1. Surgical Drapes
      • 6.1.2.2.2. Surgical Gowns
      • 6.1.2.2.3. Gloves
      • 6.1.2.2.4. Others
      • 6.1.2.3. Sterilization Consumables
      • 6.1.2.4. Infectious Waste Disposal
      • 6.1.2.5. Others
  • 6.2. By End-User
    • 6.2.1. Hospitals & Clinics
    • 6.2.2. Medical Device and Pharmaceutical Companies
    • 6.2.3. Others
  • 6.3. By Geography
    • 6.3.1. North America
      • 6.3.1.1. United States Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.1.2. Canada Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.1.3. Mexico Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.2. Europe
      • 6.3.2.1. France Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.2.2. Germany Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.2.3. United Kingdom Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.2.4. Italy Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.2.5. Spain Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.2.6. Rest of Europe Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.3. Asia-Pacific
      • 6.3.3.1. China Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.3.2. Japan Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.3.3. India Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.3.4. Australia Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.3.5. South Korea Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.3.6. Rest of Asia-Pacific Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.4. Rest of the World (RoW)
      • 6.3.4.1. Middle East Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.4.2. Africa Infection Prevention and Control Market Size in USD million (2021-2030)
      • 6.3.4.3. South America Infection Prevention and Control Market Size in USD million (2021-2030)

7. Infection Prevention and Control Market Company and Product Profiles

  • 7.1. 3M
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Fortive
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Medivators Inc
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Getinge AB
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. MELAG Medizintechnik GmbH & Co. KG
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Metrex Research, LLC
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. MMM Group
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. STERIS
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Sotera Health LLC
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Nanosonics
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. BD
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Owens & Minor
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Matachana Group
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Xenex Disinfection Services Inc.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Ecolab
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. bombayengg
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. Pal International
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD.
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. Miele Group
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. Belimed AG
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Infection Prevention and Control Market in Global (2021-2030)
  • Table 3: Infection Prevention and Control Market in Global by Product (2021-2030)
  • Table 4: Infection Prevention and Control Market in Global by End-User (2021-2030)
  • Table 5: Infection Prevention and Control Market in Global by Geography (2021-2030)
  • Table 6: Infection Prevention and Control Market in North America (2021-2030)
  • Table 7: Infection Prevention and Control Market in the US (2021-2030)
  • Table 8: Infection Prevention and Control Market in Canada (2021-2030)
  • Table 9: Infection Prevention and Control Market in Mexico (2021-2030)
  • Table 10: Infection Prevention and Control Market in Europe (2021-2030)
  • Table 11: Infection Prevention and Control Market in France (2021-2030)
  • Table 12: Infection Prevention and Control Market in Germany (2021-2030)
  • Table 13: Infection Prevention and Control Market in the United Kingdom (2021-2030)
  • Table 14: Infection Prevention and Control Market in Italy (2021-2030)
  • Table 15: Infection Prevention and Control Market in Spain (2021-2030)
  • Table 16: Infection Prevention and Control Market in the Rest of Europe (2021-2030)
  • Table 17: Infection Prevention and Control Market in Asia-Pacific (2021-2030)
  • Table 18: Infection Prevention and Control Market in China (2021-2030)
  • Table 19: Infection Prevention and Control Market in Japan (2021-2030)
  • Table 20: Infection Prevention and Control Market in India (2021-2030)
  • Table 21: Infection Prevention and Control Market in Australia (2021-2030)
  • Table 22: Infection Prevention and Control Market in South Korea (2021-2030)
  • Table 23: Infection Prevention and Control Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Infection Prevention and Control Market in the Rest of the World (2021-2030)
  • Table 25: Infection Prevention and Control Market in the Middle East (2021-2030)
  • Table 26: Infection Prevention and Control Market in Africa (2021-2030)
  • Table 27: Infection Prevention and Control Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Infection Prevention and Control Market in Global (2021-2030)
  • Figure 3: Infection Prevention and Control Market in Global by Product (2021-2030)
  • Figure 4: Infection Prevention and Control Market in Global by End-User (2021-2030)
  • Figure 5: Infection Prevention and Control Market in Global by Geography (2021-2030)
  • Figure 6: Infection Prevention and Control Market in North America (2021-2030)
  • Figure 7: Infection Prevention and Control Market in the US (2021-2030)
  • Figure 8: Infection Prevention and Control Market in Canada (2021-2030)
  • Figure 9: Infection Prevention and Control Market in Mexico (2021-2030)
  • Figure 10: Infection Prevention and Control Market in Europe (2021-2030)
  • Figure 11: Infection Prevention and Control Market in France (2021-2030)
  • Figure 12: Infection Prevention and Control Market in Germany (2021-2030)
  • Figure 13: Infection Prevention and Control Market in the United Kingdom (2021-2030)
  • Figure 14: Infection Prevention and Control Market in Italy (2021-2030)
  • Figure 15: Infection Prevention and Control Market in Spain (2021-2030)
  • Figure 16: Infection Prevention and Control Market in the Rest of Europe (2021-2030)
  • Figure 17: Infection Prevention and Control Market in Asia-Pacific (2021-2030)
  • Figure 18: Infection Prevention and Control Market in China (2021-2030)
  • Figure 19: Infection Prevention and Control Market in Japan (2021-2030)
  • Figure 20: Infection Prevention and Control Market in India (2021-2030)
  • Figure 21: Infection Prevention and Control Market in Australia (2021-2030)
  • Figure 22: Infection Prevention and Control Market in South Korea (2021-2030)
  • Figure 23: Infection Prevention and Control Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Infection Prevention and Control Market in the Rest of the World (2021-2030)
  • Figure 25: Infection Prevention and Control Market in the Middle East (2021-2030)
  • Figure 26: Infection Prevention and Control Market in Africa (2021-2030)
  • Figure 27: Infection Prevention and Control Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis